{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:00:15Z","timestamp":1792800015891,"version":"4.5.0"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cca.2025.120425","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:19:10Z","timestamp":1749755950000},"page":"120425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Diagnostic and prognostic biomarkers in Polycystic Ovary Syndrome"],"prefix":"10.1016","volume":"576","author":[{"given":"Ishanka","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareena","family":"Moar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0971-4600","authenticated-orcid":false,"given":"Pawan Kumar","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cca.2025.120425_b0005","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ncrna.2024.01.002","article-title":"Biomarker potential of competing endogenous RNA networks in Polycystic Ovary Syndrome (PCOS)","volume":"9","author":"Heidarzadehpilehrood","year":"2024","journal-title":"Non-coding RNA Res."},{"issue":"12","key":"10.1016\/j.cca.2025.120425_b0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11892-017-0956-2","article-title":"Cardiometabolic Risk in PCOS: more than a Reproductive Disorder","volume":"17","author":"Torchen","year":"2017","journal-title":"Curr. Diab. Rep."},{"issue":"2","key":"10.1016\/j.cca.2025.120425_b0015","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur. J. Endocrinol."},{"issue":"9","key":"10.1016\/j.cca.2025.120425_b0020","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome","volume":"10","author":"Joham","year":"2022","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"10.1016\/j.cca.2025.120425_b0025","doi-asserted-by":"crossref","unstructured":"Silva, M.S.B. and R.E. Campbell, Polycystic Ovary Syndrome and the Neuroendocrine Consequences of Androgen Excess, in Comprehensive Physiology. p. 3347-3369.","DOI":"10.1002\/cphy.c210025"},{"issue":"11","key":"10.1016\/j.cca.2025.120425_b0030","doi-asserted-by":"crossref","first-page":"765","DOI":"10.6061\/clinics\/2015(11)09","article-title":"Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice","volume":"70","author":"Melo","year":"2015","journal-title":"Clinics"},{"issue":"3","key":"10.1016\/j.cca.2025.120425_b0035","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum. Reprod. Update"},{"issue":"null","key":"10.1016\/j.cca.2025.120425_b0040","first-page":"9","article-title":"Polycystic ovary syndrome and its impact on women\u2019s quality of life: more than just an endocrine disorder","volume":"1","author":"Brady","year":"2009","journal-title":"Drug, Healthcare and Patient Safety"},{"issue":"5","key":"10.1016\/j.cca.2025.120425_b0045","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.fertnstert.2005.01.085","article-title":"Diagnostic criteria for polycystic ovary syndrome: a reappraisal","volume":"83","author":"Azziz","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cca.2025.120425_b0050","doi-asserted-by":"crossref","unstructured":"group, T.R.E.A.s.P.c.w., Revised 2003 consensus on diagnostic criteria and long\u2010term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction, 2004. 19(1): p. 41-47.","DOI":"10.1093\/humrep\/deh098"},{"issue":"11","key":"10.1016\/j.cca.2025.120425_b0055","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Criteria for defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: an Androgen Excess Society Guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/j.cca.2025.120425_b0060","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2009","journal-title":"Hum. Reprod."},{"issue":"5","key":"10.1016\/j.cca.2025.120425_b0065","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jc.2015-4009","article-title":"Defining hyperandrogenism in women with polycystic ovary syndrome: a challenging perspective","volume":"101","author":"Pasquali","year":"2016","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"3","key":"10.1016\/j.cca.2025.120425_b0070","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tem.2014.12.004","article-title":"Functional genomics of PCOS: from GWAS to molecular mechanisms","volume":"26","author":"McAllister","year":"2015","journal-title":"Trends in Endocrinology & Metabolism"},{"issue":"2","key":"10.1016\/j.cca.2025.120425_b0075","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S2213-8587(19)30345-6","article-title":"Diabetes: a metabolic and reproductive disorder in women","volume":"8","author":"Thong","year":"2020","journal-title":"The Lancet Diabetes & Endocrinology"},{"issue":"5","key":"10.1016\/j.cca.2025.120425_b0080","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"7","key":"10.1016\/j.cca.2025.120425_b0085","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1210\/jc.2006-2274","article-title":"Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women","volume":"92","author":"Jain","year":"2007","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/biomedicines7010005","article-title":"Hypothalamic-pituitary-ovarian axis disorders impacting female fertility","volume":"7","author":"Mikhael","year":"2019","journal-title":"Biomedicines"},{"issue":"1\u20132","key":"10.1016\/j.cca.2025.120425_b0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mce.2005.07.002","article-title":"Insulin regulation of GnRH gene expression through MAP kinase signaling pathways","volume":"242","author":"Kim","year":"2005","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"10.1016\/j.cca.2025.120425_b0100","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1507\/endocrj.K09E-185","article-title":"GnRH pulsatility, the pituitary response and reproductive dysfunction","volume":"56","author":"Tsutsumi","year":"2009","journal-title":"Endocr. J."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/en.2003-0329","article-title":"Insulin augmentation of 17\u03b1-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1\/2 in human ovarian theca cells","volume":"145","author":"Munir","year":"2004","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.cca.2025.120425_b0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/EJE-10-0782","article-title":"Insulin enhances ACTH-stimulated androgen and glucocorticoid metabolism in hyperandrogenic women","volume":"164","author":"Tosi","year":"2011","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0115","first-page":"240","volume":"88","author":"Wang","year":"2007","journal-title":"The Effect of Cinnamon Extract on Insulin Resistance Parameters in Polycystic Ovary Syndrome: a Pilot Study."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0120","first-page":"55","volume":"72","author":"Emam","year":"2021","journal-title":"Linum Usitatissimum Seeds Oil down-Regulates mRNA Expression for the Steroidogenic Acute Regulatory Protein and Cyp11A1 Genes, Ameliorating Letrezole-Induced Polycystic Ovarian Syndrome in a Rat Model."},{"issue":"4","key":"10.1016\/j.cca.2025.120425_b0125","first-page":"205","volume":"33","author":"Westphal","year":"2006","journal-title":"Double-Blind, Placebo-Controlled Study of Fertilityblend: a Nutritional Supplement for Improving Fertility in Women."},{"issue":"2","key":"10.1016\/j.cca.2025.120425_b0130","first-page":"148","volume":"21","author":"Barazesh","year":"2016","journal-title":"The Effect of Hydroalcoholic Extract of Glycyrrhizaglabra L. (licorice) Root on Serum Level of Glucose, Triglyceride and Cholesterol in Polycystic Ovary Syndrome Induced by Letrozole in Rats."},{"issue":"6","key":"10.1016\/j.cca.2025.120425_b0135","first-page":"714","volume":"22","author":"Zand Vakili","year":"2018","journal-title":"The Effect of Evening Primrose Oil on Changes in Polycystic Ovary Syndrome Induced by Estradiol Valerate in Rat."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0140","first-page":"130","volume":"3","author":"Koppisetti","year":"2025","journal-title":"A Review of Therapeutic Applications of Nutraceuticals in Polycystic Ovarian Disease."},{"issue":"4","key":"10.1016\/j.cca.2025.120425_b0145","first-page":"273","volume":"1","author":"Maharjan","year":"2010","journal-title":"Effect of Aloe Barbadensis Mill. Formulation on Letrozole Induced Polycystic Ovarian Syndrome Rat Model."},{"key":"10.1016\/j.cca.2025.120425_b0150","volume":"138","author":"Zhang","year":"2021","journal-title":"Effect and Mechanism of Berberine against Polycystic Ovary Syndrome."},{"key":"10.1016\/j.cca.2025.120425_b0155","unstructured":"ZZ, F., Effects of chamomile extract on biochemical and clinical parameters in a rat model of polycystic ovary syndrome. 2010."},{"key":"10.1016\/j.cca.2025.120425_b0160","first-page":"1139","volume":"84","author":"Pak","year":"2005","journal-title":"Role of Korean Red Ginseng Total Saponins in Rat Infertility Induced by Polycystic Ovaries."},{"issue":"11","key":"10.1016\/j.cca.2025.120425_b0165","first-page":"1708","volume":"27","author":"Jalilian","year":"2013","journal-title":"Phytotherapeutic Management of Polycystic Ovary Syndrome: Role of Aerial Parts of Wood Betony (stachys Lavandulifolia)."},{"issue":"10","key":"10.1016\/j.cca.2025.120425_b0170","first-page":"344","article-title":"Role of Foeniculum vulgare in PCOS\u2014A","volume":"8","author":"Meena","year":"2019","journal-title":"Review Article."},{"issue":"4","key":"10.1016\/j.cca.2025.120425_b0175","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/1354750X.2023.2179114","article-title":"Potential biomarkers in endometrial cancer: a narrative review","volume":"28","author":"Moar","year":"2023","journal-title":"Biomarkers"},{"key":"10.1016\/j.cca.2025.120425_b0180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/TACG.S200341","article-title":"Genetic basis of polycystic ovary syndrome (PCOS): current perspectives","author":"Khan","year":"2019","journal-title":"Appl. Clin. Genet."},{"issue":"6","key":"10.1016\/j.cca.2025.120425_b0185","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.fertnstert.2005.01.096","article-title":"Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups","volume":"83","author":"Chang","year":"2005","journal-title":"Fertil. Steril."},{"issue":"19","key":"10.1016\/j.cca.2025.120425_b0190","doi-asserted-by":"crossref","first-page":"11952","DOI":"10.3390\/ijms231911952","article-title":"The roles of androgens in humans: biology, metabolic regulation and health","volume":"23","author":"Alemany","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2025.120425_b0195","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bpobgyn.2016.03.005","article-title":"Hypothalamic\u2013pituitary, ovarian and adrenal contributions to polycystic ovary syndrome","volume":"37","author":"Baskind","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"4","key":"10.1016\/j.cca.2025.120425_b0200","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/j.2040-4603.2014.tb00590.x","article-title":"Adrenal androgens and androgen precursors: definition, synthesis, regulation and physiologic actions","volume":"4","author":"Turcu","year":"2014","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.cca.2025.120425_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1273542","article-title":"Androgen excess: a hallmark of polycystic ovary syndrome","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"11","key":"10.1016\/j.cca.2025.120425_b0210","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","article-title":"A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)","volume":"39","author":"Siddiqui","year":"2022","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.cca.2025.120425_b0215","article-title":"PCOS and the Rhythmicity of GnRH: the Impact of FSH and LH on Menstrual Health. Obstetrics and Gynecology","volume":"27","author":"Maheshwari","year":"2023","journal-title":"Advances"},{"key":"10.1016\/j.cca.2025.120425_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-020-00569-6","article-title":"Role of anti-M\u00fcllerian hormone and testosterone in follicular growth: a cross-sectional study","volume":"20","author":"Lv","year":"2020","journal-title":"BMC Endocr. Disord."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-020-03576-x","article-title":"New insights into anti-M\u00fcllerian hormone role in the hypothalamic\u2013pituitary\u2013gonadal axis and neuroendocrine development","volume":"78","author":"Silva","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cca.2025.120425_b0230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.coemr.2020.04.006","article-title":"AMH in PCOS: Controlling the ovary, placenta, or brain?","volume":"12","author":"Moolhuijsen","year":"2020","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0235","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0240","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jc.2006-1582","article-title":"Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries","volume":"92","author":"Pellatt","year":"2007","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/j.cca.2025.120425_b0245","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.cca.2025.120425_b0250","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.fertnstert.2014.10.033","article-title":"Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antim\u00fcllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study","volume":"103","author":"Bhide","year":"2015","journal-title":"Fertil. Steril."},{"issue":"11","key":"10.1016\/j.cca.2025.120425_b0255","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","article-title":"Anti-M\u00fcllerian hormone and ovarian reserve: update on assessing ovarian function","volume":"105","author":"Moolhuijsen","year":"2020","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"36","key":"10.1016\/j.cca.2025.120425_b0260","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.2174\/1381612822666160720155855","article-title":"Insulin resistance and polycystic ovary syndrome","volume":"22","author":"Moghetti","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cca.2025.120425_b0265","unstructured":"Orbetzova, M.M., Clinical impact of insulin resistance in women with polycystic ovary syndrome, in Polycystic Ovarian Syndrome. 2020, IntechOpen."},{"issue":"5","key":"10.1016\/j.cca.2025.120425_b0270","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0275","doi-asserted-by":"crossref","DOI":"10.1515\/bmc-2022-0038","article-title":"Polycystic ovary syndrome and its management: In view of oxidative stress","volume":"15","author":"Bhattacharya","year":"2024","journal-title":"Biomol. Concepts"},{"issue":"3","key":"10.1016\/j.cca.2025.120425_b0280","first-page":"123","article-title":"Homeostatic model assessment for insulin resistance (HOMA-IR): a better marker for evaluating insulin resistance than fasting insulin in women with polycystic ovarian syndrome","volume":"27","author":"Majid","year":"2017","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"10.1016\/j.cca.2025.120425_b0285","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-0038-1642634","article-title":"Association between insulin resistance and cardiovascular risk factors in polycystic ovary syndrome patients","volume":"40","author":"Wanderley","year":"2018","journal-title":"Revista Brasileira De Ginecologia e Obstetr\u00edcia"},{"issue":"12","key":"10.1016\/j.cca.2025.120425_b0290","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.cca.2025.120425_b0295","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000089191.72957.ED","article-title":"Endothelial function testing as a biomarker of vascular disease","volume":"108","author":"Verma","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cca.2025.120425_b0300","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","article-title":"Low grade chronic inflammation in women with polycystic ovarian syndrome","volume":"86","author":"Kelly","year":"2001","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0305","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4092470","article-title":"Inflammatory markers in women with polycystic ovary syndrome","volume":"2020","author":"Rudnicka","year":"2020","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.cca.2025.120425_b0310","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejogrb.2017.05.014","article-title":"The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women","volume":"214","author":"Tola","year":"2017","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"3","key":"10.1016\/j.cca.2025.120425_b0315","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/09513590.2014.976546","article-title":"The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome","volume":"31","author":"Souza dos Santos","year":"2015","journal-title":"Gynecol. Endocrinol."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0320","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2004-0628","article-title":"The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome","volume":"90","author":"Orio","year":"2005","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"3","key":"10.1016\/j.cca.2025.120425_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis","volume":"95","author":"Escobar-Morreale","year":"2011","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.cca.2025.120425_b0330","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmr025","article-title":"Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome","volume":"17","author":"Toulis","year":"2011","journal-title":"Hum. Reprod. Update"},{"issue":"6","key":"10.1016\/j.cca.2025.120425_b0335","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/humrep\/del003","article-title":"Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin","volume":"21","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Hum. Reprod."},{"issue":"12","key":"10.1016\/j.cca.2025.120425_b0340","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3109\/09513590.2012.683082","article-title":"Mediators of chronic inflammation in polycystic ovarian syndrome","volume":"28","author":"Deligeoroglou","year":"2012","journal-title":"Gynecol. Endocrinol."},{"issue":"4","key":"10.1016\/j.cca.2025.120425_b0345","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.fertnstert.2008.10.070","article-title":"Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors","volume":"93","author":"Kaya","year":"2010","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.cca.2025.120425_b0350","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1210\/jc.2003-031365","article-title":"Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity","volume":"89","author":"Escobar-Morreale","year":"2004","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"5","key":"10.1016\/j.cca.2025.120425_b0355","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-2265.2009.03523.x","article-title":"Plasma monocyte chemoattractant protein\u20101 (MCP\u20101) and macrophage inflammatory protein\u20101\u03b1 are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment","volume":"71","author":"Glintborg","year":"2009","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0360","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejogrb.2011.03.015","article-title":"Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome","volume":"157","author":"Hu","year":"2011","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"7","key":"10.1016\/j.cca.2025.120425_b0365","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.metabol.2009.02.022","article-title":"Evidence of proatherogenic inflammation in polycystic ovary syndrome","volume":"58","author":"Gonz\u00e1lez","year":"2009","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.cca.2025.120425_b0370","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.yjmcc.2008.06.003","article-title":"CCL3 (MIP-1\u03b1) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events","volume":"45","author":"de Jager","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0375","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.fertnstert.2011.11.023","article-title":"Is PCOS an inflammatory process?","volume":"97","author":"Duleba","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cca.2025.120425_b0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-016-0205-6","article-title":"Relationship between advanced glycation end products and steroidogenesis in PCOS","volume":"14","author":"Garg","year":"2016","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0385","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/humrep\/det383","article-title":"Advanced glycation end products and their relevance in female reproduction","volume":"29","author":"Merhi","year":"2014","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0390","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2265.2004.02170.x","article-title":"Increased levels of serum advanced glycation end\u2010products in women with polycystic ovary syndrome","volume":"62","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0395","doi-asserted-by":"crossref","first-page":"91","DOI":"10.14310\/horm.2002.1563","article-title":"White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia","volume":"14","author":"Papalou","year":"2015","journal-title":"Hormones"},{"issue":"3","key":"10.1016\/j.cca.2025.120425_b0400","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/01443615.2011.553693","article-title":"Polycystic ovary syndrome and the peripheral blood white cell count","volume":"31","author":"Herlihy","year":"2011","journal-title":"J. Obstet. Gynaecol."},{"issue":"1\u20132","key":"10.1016\/j.cca.2025.120425_b0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(01)00393-X","article-title":"Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins","volume":"306","author":"Abuja","year":"2001","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.cca.2025.120425_b0410","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/humupd\/dms059","article-title":"Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis","volume":"19","author":"Murri","year":"2013","journal-title":"Hum. Reprod. Update"},{"issue":"5","key":"10.1016\/j.cca.2025.120425_b0415","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/00016340902859315","article-title":"Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome","volume":"88","author":"Ku\u015f\u00e7u","year":"2009","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"3","key":"10.1016\/j.cca.2025.120425_b0420","first-page":"421","article-title":"The effects of oxidative stress to PCOS. Sichuan da xue xue bao. Yi xue ban=","volume":"39","author":"Zhang","year":"2008","journal-title":"Journal of Sichuan University. Medical Science Edition"},{"issue":"2","key":"10.1016\/j.cca.2025.120425_b0425","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.2006.03061.x","article-title":"The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients","volume":"144","author":"Palacio","year":"2006","journal-title":"Clinical & Experimental Immunology"},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0430","first-page":"27","article-title":"Oxidative stress status, metabolic profile and cardiovascular risk factors in patients with polycystic ovary syndrome","volume":"1","author":"Ergen","year":"2012","journal-title":"Medicine Science"},{"issue":"2","key":"10.1016\/j.cca.2025.120425_b0435","first-page":"111","article-title":"Nitric oxide-induced polycystic ovaries in the Wistar rat","volume":"6","author":"Hassani","year":"2012","journal-title":"International Journal of Fertility & Sterility"},{"issue":"2","key":"10.1016\/j.cca.2025.120425_b0440","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejogrb.2006.09.009","article-title":"Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity","volume":"133","author":"N\u00e1cul","year":"2007","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"3","key":"10.1016\/j.cca.2025.120425_b0445","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jjcc.2012.01.013","article-title":"The relationships among hyperuricemia, endothelial dysfunction, and cardiovascular diseases: molecular mechanisms and clinical implications","volume":"59","author":"Puddu","year":"2012","journal-title":"J. Cardiol."},{"issue":"3","key":"10.1016\/j.cca.2025.120425_b0450","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-0412.2011.01337.x","article-title":"Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome","volume":"91","author":"Baskol","year":"2012","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.cca.2025.120425_b0455","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jri.2016.06.002","article-title":"Is Xanthine oxidase activity in polycystic ovary syndrome associated with inflammatory and cardiovascular risk factors?","volume":"116","author":"Is\u0131k","year":"2016","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.cca.2025.120425_b0460","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00018.2001","article-title":"Free radicals in the physiological control of cell function","author":"Dr\u00f6ge","year":"2002","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.cca.2025.120425_b0465","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0009-9120(01)00245-4","article-title":"Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease\u2606","volume":"34","author":"Sabuncu","year":"2001","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2025.120425_b0470","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10815-014-0190-7","article-title":"Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection","volume":"31","author":"Seleem","year":"2014","journal-title":"J. Assist. Reprod. Genet."},{"issue":"6","key":"10.1016\/j.cca.2025.120425_b0475","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0168-8278(01)00037-X","article-title":"Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes","volume":"34","author":"Hammond","year":"2001","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.cca.2025.120425_b0480","article-title":"DNA damage, DNA susceptibility to oxidation and glutathione level in women with polycystic ovary syndrome","volume":"65","author":"Akcay","year":"2005","journal-title":"Scand. J. Clin. Lab. Investig."},{"issue":"7","key":"10.1016\/j.cca.2025.120425_b0485","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Trends in Endocrinology & Metabolism"},{"issue":"8","key":"10.1016\/j.cca.2025.120425_b0490","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa061","article-title":"ApoB48-lipoproteins are associated with cardiometabolic risk in adolescents with and without polycystic ovary syndrome","volume":"4","author":"Vine","year":"2020","journal-title":"J. Endocr. Soc."},{"issue":"6","key":"10.1016\/j.cca.2025.120425_b0495","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/09513590.2019.1698026","article-title":"Ceramide subclasses identified as novel lipid biomarker elevated in women with polycystic ovary syndrome: a pilot study employing shotgun lipidomics","volume":"36","author":"Jiang","year":"2020","journal-title":"Gynecol. Endocrinol."},{"issue":"3","key":"10.1016\/j.cca.2025.120425_b0500","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/humupd\/dmp006","article-title":"Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis","volume":"15","author":"Toulis","year":"2009","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.cca.2025.120425_b0505","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.537809","article-title":"Circulating adipokine levels in nonobese women with polycystic ovary syndrome and in nonobese control women: a systematic review and meta-analysis","volume":"11","author":"Lin","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"10","key":"10.1016\/j.cca.2025.120425_b0510","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.3390\/biomedicines10102503","article-title":"The complex roles of adipokines in polycystic ovary syndrome and endometriosis","volume":"10","author":"Sch\u00fcler-Toprak","year":"2022","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.cca.2025.120425_b0515","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/CBI20100542","article-title":"Altered expression of Bcl\u20102 and Bax in follicles within dehydroepiandrosterone\u2010induced polycystic ovaries in rats","volume":"35","author":"Bas","year":"2011","journal-title":"Cell Biol. Int."},{"issue":"9","key":"10.1016\/j.cca.2025.120425_b0520","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1093\/humrep\/dei068","article-title":"Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF","volume":"20","author":"Onalan","year":"2005","journal-title":"Hum. Reprod."},{"issue":"6","key":"10.1016\/j.cca.2025.120425_b0525","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/life14060722","article-title":"An update on physiopathological roles of Akt in the ReprodAKTive mammalian ovary","volume":"14","author":"Giaccari","year":"2024","journal-title":"Life"},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0530","doi-asserted-by":"crossref","first-page":"11648","DOI":"10.1038\/s41598-023-38340-1","article-title":"Evaluation of the p53 pathway in polycystic ovarian syndrome pathogenesis and apoptosis enhancement in human granulosa cells through transcriptome data analysis","volume":"13","author":"Zanjirband","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.cca.2025.120425_b0535","first-page":"1707","volume":"309","author":"Rashid","year":"2024","journal-title":"miRNA Expression in PCOS: Unveiling a Paradigm Shift toward Biomarker Discovery."},{"key":"10.1016\/j.cca.2025.120425_b0540","first-page":"355","volume":"31","author":"Roth","year":"2014","journal-title":"Altered microRNA and Gene Expression in the Follicular Fluid of Women with Polycystic Ovary Syndrome."},{"issue":"2","key":"10.1016\/j.cca.2025.120425_b0545","first-page":"903","volume":"25","author":"Nasser","year":"2024","journal-title":"The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: a Literature Review."},{"key":"10.1016\/j.cca.2025.120425_b0550","first-page":"5","volume":"15","author":"Mladenov","year":"2025","journal-title":"Selected microRNAs as Potential Diagnostic Biomarkers in Polycystic Ovary Syndrome in Adolescent Girls."},{"issue":"16","key":"10.1016\/j.cca.2025.120425_b0555","volume":"7","author":"Song","year":"2019","journal-title":"Serum Testosterone Acts as a Prognostic Indicator in Polycystic Ovary Syndrome-Associated Kidney Injury."},{"key":"10.1016\/j.cca.2025.120425_b0560","doi-asserted-by":"crossref","unstructured":"Bonventre, J.V.J.N.D.T., Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. 2009, Oxford University Press. p. 3265-3268.","DOI":"10.1093\/ndt\/gfp010"},{"key":"10.1016\/j.cca.2025.120425_b0565","volume":"36","author":"Huffman","year":"2023","journal-title":"Biomarkers in Polycystic Ovary Syndrome."},{"issue":"5","key":"10.1016\/j.cca.2025.120425_b0570","first-page":"619","volume":"30","author":"Takayama","year":"2011","journal-title":"Integration of Cap Analysis of Gene Expression and Chromatin Immunoprecipitation Analysis on Array Reveals Genome-Wide Androgen Receptor Signaling in Prostate Cancer Cells."},{"issue":"5","key":"10.1016\/j.cca.2025.120425_b0575","first-page":"363","volume":"31","author":"Liu","year":"2015","journal-title":"Peripheral Blood Leukocyte Expression Level of lncRNA Steroid Receptor RNA Activator (SRA) and Its Association with Polycystic Ovary Syndrome: a Case Control Study."},{"key":"10.1016\/j.cca.2025.120425_b0580","first-page":"1","volume":"19","author":"Mu","year":"2021","journal-title":"Non-Coding RNAs in Polycystic Ovary Syndrome: a Systematic Review and Meta-Analysis."},{"key":"10.1016\/j.cca.2025.120425_b0585","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/IJWH.S344542","article-title":"Effect of sex hormone-binding globulin on polycystic ovary syndrome: mechanisms, manifestations, genetics, and treatment","author":"Xing","year":"2022","journal-title":"Int. J. Womens Health"},{"issue":"12","key":"10.1016\/j.cca.2025.120425_b0590","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1210\/en.2015-1677","article-title":"SHBG-C57BL\/ksJ-db\/db: a new mouse model to study SHBG expression and regulation during obesity development","volume":"156","author":"Sa\u00e9z-L\u00f3pez","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2025.120425_b0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12905-017-0373-3","article-title":"Sex hormone binding globulin as a valuable biochemical marker in predicting gestational diabetes mellitus","volume":"17","author":"Tawfeek","year":"2017","journal-title":"BMC Womens Health"},{"issue":"3","key":"10.1016\/j.cca.2025.120425_b0600","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MED.0b013e328353732f","article-title":"Evolving utility of sex hormone-binding globulin measurements in clinical medicine","volume":"19","author":"Hammond","year":"2012","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0605","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/19396368.2017.1410591","article-title":"Sex hormone binding globulin-an important biomarker for predicting PCOS risk: a systematic review and meta-analysis","volume":"64","author":"Deswal","year":"2018","journal-title":"Syst. Biol. Reprod. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120425_b0610","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.rbmo.2020.10.003","article-title":"Association between human SHBG gene polymorphisms and risk of PCOS: a meta-analysis","volume":"42","author":"Li","year":"2021","journal-title":"Reprod. Biomed. Online"}],"updated-by":[{"DOI":"10.1016\/j.cca.2025.120464","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000}}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125003043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125003043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:07:20Z","timestamp":1762114040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125003043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":122,"alternative-id":["S0009898125003043"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120425","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic and prognostic biomarkers in Polycystic Ovary Syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120425"}}